Posted by Michael Wonder on 13 May 2021
Pfizer warns that IP waiver for COVID-19 vaccines may invite ‘copycat medicines’
13 May 2021 - Company says removing intellectual property protections would make it ‘harder’ to make vaccines in the short term.
Pfizer has cautioned against removing intellectual property protections in a submission to an Australian parliamentary inquiry into vaccine fraud.
